Fort Sheridan Advisors LLC Has $2.64 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Fort Sheridan Advisors LLC trimmed its stake in shares of Kenvue Inc. (NYSE:KVUE) by 2.9% during the fourth quarter, Holdings Channel reports. The firm owned 123,397 shares of the company’s stock after selling 3,717 shares during the period. Fort Sheridan Advisors LLC’s holdings in Kenvue were worth $2,635,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. AMF Tjanstepension AB boosted its stake in Kenvue by 187.3% in the 3rd quarter. AMF Tjanstepension AB now owns 120,477 shares of the company’s stock valued at $2,787,000 after buying an additional 78,540 shares in the last quarter. International Assets Investment Management LLC boosted its stake in shares of Kenvue by 1,529.5% in the 3rd quarter. International Assets Investment Management LLC now owns 106,341 shares of the company’s stock valued at $2,460,000 after purchasing an additional 99,815 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Kenvue by 28.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 228,598 shares of the company’s stock worth $5,287,000 after purchasing an additional 50,073 shares during the last quarter. abrdn plc increased its position in shares of Kenvue by 298.7% during the 3rd quarter. abrdn plc now owns 708,047 shares of the company’s stock worth $16,409,000 after purchasing an additional 530,444 shares in the last quarter. Finally, Pathway Financial Advisers LLC lifted its holdings in Kenvue by 107.7% during the 3rd quarter. Pathway Financial Advisers LLC now owns 10,657 shares of the company’s stock valued at $247,000 after purchasing an additional 5,526 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

KVUE has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $25.00 to $24.00 in a report on Thursday, December 12th. Piper Sandler lifted their price objective on Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday. Canaccord Genuity Group decreased their target price on Kenvue from $27.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, February 7th. UBS Group lowered their target price on Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Finally, Citigroup reduced their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 15th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $23.08.

Kenvue Stock Down 0.3 %

Shares of Kenvue stock opened at $23.15 on Friday. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The business has a fifty day simple moving average of $21.42 and a 200 day simple moving average of $22.24. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The stock has a market cap of $44.24 billion, a PE ratio of 43.67, a price-to-earnings-growth ratio of 2.62 and a beta of 1.45.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were issued a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.54%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.